Gilbert R Kaufmann
Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
Kaufmann G, Battegay M, Hirschel B, Bernasconi E, Vernazza P, Giulieri S, Furrer H, Weber R, Elzi L, Swiss HIV Cohort Study. Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. AIDS 2011; 25:441-51.
20.02.2011Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
20.02.2011AIDS 2011; 25:441-51
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Bernasconi Enos, Vernazza Pietro, Giulieri Stefano, Furrer Hansjakob, Weber Rainer, Elzi Luigia, Swiss HIV Cohort Study
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
Khanna N, Kaufmann G, Battegay M, Hirschel B, Weber R, Bernasconi E, Vernazza P, Cavassini M, Furrer H, Opravil M, Swiss HIV Cohort Study. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101.
15.10.2008CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
15.10.2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101
Khanna Nina, Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Opravil Milos, Swiss HIV Cohort Study
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
Kaufmann G, Battegay M, Hirschel B, Rickenbach M, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Perrin L, Ledergerber B, Furrer H, Swiss HIV Cohort Study. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:361-72.
01.08.2005Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
01.08.2005Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:361-72
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Rickenbach Martin, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Perrin Luc, Ledergerber Bruno, Furrer Hansjakob, Swiss HIV Cohort Study
Gynecomastia and potent antiretroviral therapy
Strub C, Kaufmann G, Flepp M, Egger M, Kahlert C, Cavassini M, Battegay M. Gynecomastia and potent antiretroviral therapy. AIDS (London, England) 2004; 18:1347-9.
18.06.2004Gynecomastia and potent antiretroviral therapy
18.06.2004AIDS (London, England) 2004; 18:1347-9
Strub Christoph, Kaufmann Gilbert R, Flepp Markus, Egger Martin, Kahlert Christian, Cavassini Matthias, Battegay Manuel
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
Kaufmann G, Battegay M, Hirschel B, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Cavassini M, Furrer H, Perrin L, Weber R, Khanna N, Swiss HIV Cohort Study. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection. Antiviral therapy 2004; 9:263-74.
01.04.2004Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
01.04.2004Antiviral therapy 2004; 9:263-74
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Cavassini Matthias, Furrer Hansjakob, Perrin Luc, Weber Rainer, Khanna Nina, Swiss HIV Cohort Study
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
Kaufmann G, Battegay M, Egger M, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Hirschel B, Telenti A, Furrer H, Opravil M, Pantaleo G, Perrin L, Swiss HIV Cohort Study Group. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Archives of internal medicine 2003; 163:2187-95.
13.10.2003CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
13.10.2003Archives of internal medicine 2003; 163:2187-95
Kaufmann Gilbert R, Battegay Manuel, Egger Matthias, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Hirschel Bernard, Telenti Amalio, Furrer Hansjakob, Opravil Milos, Pantaleo Guiseppe, Perrin Luc, Swiss HIV Cohort Study Group